Sheela Foam logo

Sheela Foam

SFL NSE

Key Fundamentals

MicrocapHome FurnishingConsumer Goods
Market Cap
₹7,605 Cr
Volatility
Moderate
P/E Ratio
35.14
EBITDA
₹448 Cr
Return on Equity
4.28%
Debt to Equity
0.28
Book Value
₹297.79
EPS
₹12.09
52W High
₹832.45
52W Low
₹456.8

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

1
  • Company has reduced debt.

Weaknesses

4
  • The company has delivered a poor sales growth of 9.41% over past five years.
  • Company has a low return on equity of 3.86% over last 3 years.
  • Dividend payout has been low at 2.28% of profits over last 3 years
  • Promoter holding has decreased over last 3 years: -7.56%

Growth Rate

Revenue Growth
8.54% lower than 3Y
Net Income Growth
56.92% higher than 3Y
Cash Flow Change
65.46% higher than 3Y
ROE
45.58% higher than 3Y
ROCE
33.04% higher than 3Y
EBITDA Margin (Avg.)
9.69% higher than 3Y

AI Analysis — Bull vs Bear

Anthropic anthropic claude-opus-4.6 44d ago
AI opinion · based on fundamentals
Risk high

Sheela Foam Ltd trades at a market cap of ~₹8,461 Cr with a PE of 52.8x and a 3-year ROE averaging just 4%, reflecting a premium valuation on still-recovering profitability. Consolidated revenue grew 15% YoY in FY25 to ₹3,439 Cr, and TTM profit surged 336% off a low base, but 5-year compounded profit growth remains negative at -8%.

Bull Case 8
  • Market leader in organized mattresses with ~30% combined share (Sleepwell ~18% + Kurlon ~11%), giving pricing power and distribution dominance with over 5,000 exclusive outlets
  • Consolidated revenue grew 15% YoY in FY25 to ₹3,439 Cr, with compounded sales CAGR of 10% over 3 years indicating consistent top-line expansion
  • TTM profit growth of 336% YoY signals a strong recovery from trough earnings, with Q4FY26 EBITDA surging 336% YoY and PAT rising 589% YoY
  • Gross margins improved to 42.5-44.9% in FY25 from ~40% levels in FY24, reflecting better product mix and easing raw material costs
  • Kurlon integration 75-80% complete by Dec 2024, targeting ₹1,000 Cr annual run rate from Kurlon alone and EBITDA margin target of 14-15% by 2027
  • Company has reduced debt, strengthening balance sheet flexibility for brand investments and distribution expansion
  • International operations showing recovery — Australia (Joyce) EBITDA margins at 53.6% vs 48.4% prior, Spain (Interplasp) gross margin at 33.6% vs 32%
  • India mattress market shift from unorganized (~65%) to organized segment provides a long structural growth runway for the market leader
Bear Case 8
  • PE of 52.8x is elevated for a company with 5-year compounded profit CAGR of -8% and 3-year profit CAGR of -7%, implying valuation prices in significant future improvement
  • 3-year average ROE of just 4% (last year 5%) is very low for a consumer discretionary company, indicating poor capital efficiency
  • Promoter holding decreased by 7.56% over last 3 years (currently ~65.4%), signaling potential dilution or promoter exit
  • Dividend payout at only 2.28% of profits over 3 years with a yield of 0.13%, offering negligible income return to shareholders
  • 5-year sales CAGR of only 9% is modest for a company at this valuation multiple, and stock CAGR is -8% over 5 years and -14% over 3 years
  • EBITDA margins remain compressed at 8-10% levels in FY25, well below the 14-15% long-term target, with margin recovery repeatedly missing estimates
  • PB ratio of 2.61x against low single-digit ROE implies the market is paying a premium for assets that are currently generating subpar returns
  • Integration risks remain with Kurlon acquisition — Q4FY25 and Q1FY26 results missed estimates on revenue, EBITDA, and PAT due to seasonal weakness and margin pressures

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

Anthropic anthropic claude-opus-4.6 42d ago
Positives 1
  • FY26 revenue up 11% Jul 13

    Sheela Foam reported consolidated revenue of ₹3,821 crore for FY26, an 11% increase YoY. Net profit rose to ₹161 crore, supported by volume growth and margin expansion.

Neutral 1
  • Q1FY27 earnings call scheduled Aug 2

    Sheela Foam is hosting an investor and analyst conference call on August 5, 2026, to discuss Q1FY27 financial results, featuring key executives with global dial-in access.

TL;DR: Sheela Foam is delivering steady top-line growth with FY26 revenue rising 11% to ₹3,821 crore and net profit improving to ₹161 crore on volume growth and margin expansion. No specific headwinds are visible in recent news. The upcoming Q1FY27 earnings call on Aug 5 will be key to confirming whether the growth momentum is sustaining into the new fiscal year.

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
645
613
879
845
810
813
967
850
821
875
1,074
1,050
1,032
Expenses
567
547
803
765
750
742
879
823
746
788
960
933
923
Operating Profit
78
66
76
81
60
70
88
27
75
87
114
117
109
OPM %
12%
11%
9%
10%
7%
9%
9%
3.1%
9%
10%
11%
11%
11%
Other Income
13
24
32
70
61
32
8
61
10
3
16
34
22
Interest
8
9
25
27
28
28
29
35
29
28
17
21
18
Depreciation
23
22
30
41
40
48
45
50
46
50
47
36
34
PBT
60
60
53
83
53
26
22
2
10
12
66
94
80
Tax %
28%
26%
27%
17%
12%
23%
25%
-496%
50%
38%
25%
18%
26%
Net Profit
43
44
31
65
47
20
17
13
7
10
53
92
62
EPS in Rs
4.41
4.04
2.83
5.94
4.23
1.83
1.54
1.2
0.6
0.89
4.8
8.36
5.63
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
1,359
1,550
1,680
1,889
2,066
2,121
2,437
2,866
2,873
2,982
3,439
3,821
4,031
Expenses
1,268
1,374
1,484
1,672
1,855
1,821
2,073
2,550
2,575
2,678
3,187
3,426
3,604
Operating Profit
91
176
196
217
211
300
364
315
298
304
252
395
427
OPM %
7%
11%
12%
11%
10%
14%
15%
11%
10%
10%
7%
10%
11%
Other Income
11
16
23
21
28
28
50
79
86
136
154
60
75
Interest
16
12
11
9
10
13
18
17
21
69
121
95
84
Depreciation
28
29
30
35
40
59
73
81
90
116
183
179
166
PBT
58
152
178
193
189
256
324
296
273
256
103
182
252
Tax %
26%
31%
29%
31%
29%
24%
26%
26%
26%
24%
14%
23%
—
Net Profit
43
105
126
134
134
194
240
219
201
184
90
161
217
EPS in Rs
13.13
32.22
12.86
13.7
13.7
19.82
24.36
22.27
20.39
16.78
8.22
14.62
19.68
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
7%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
16
16
24
24
24
24
24
24
49
54
55
55
Reserves
229
322
439
573
706
895
1,160
1,368
1,549
2,866
2,962
3,197
Borrowings
146
115
59
48
31
310
334
466
571
1,493
1,462
908
Other Liabilities
289
335
395
398
401
414
551
496
533
909
881
949
Total Liabilities
679
788
918
1,043
1,162
1,644
2,069
2,355
2,702
5,322
5,360
5,109
Fixed Assets
286
288
318
348
412
851
894
883
865
3,129
3,080
3,198
CWIP
8
10
36
52
1
18
33
120
287
166
131
32
Investments
0
10
0
98
318
231
411
618
768
878
873
588
Other Assets
385
481
564
544
432
544
732
734
781
1,150
1,276
1,291
Total Assets
679
788
918
1,043
1,162
1,644
2,069
2,355
2,702
5,322
5,360
5,109
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
147
159
122
134
138
157
254
197
218
406
247
409
Investing
-49
-34
2
-80
-246
-287
-208
-306
-272
-2,258
-24
298
Financing
-59
-25
-67
-20
-27
157
-32
93
56
1,854
-226
-716
Net Cash Flow
40
100
57
34
-135
27
13
-17
1
2
-3
-8
Free Cash Flow
93
108
34
52
86
-245
191
54
2
-1,870
146
368
CFO/OP
171
111
101
87
93
66
92
92
100
162
100
111
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
31
28
30
28
27
37
45
34
36
45
37
42
Inventory Days
52
49
59
60
60
81
87
64
71
73
66
69
Days Payable
57
52
64
51
46
55
91
58
55
83
66
80
Cash Conversion Cycle
26
24
25
37
41
63
41
40
51
34
37
31
Working Capital Days
-18
-28
-9
2
10
19
14
14
0
-39
-63
-51
ROCE %
19%
38%
39%
35%
28%
26%
23%
18%
14%
8%
4%
6%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Sheela Foam insights

65 extracted metrics + investor summaries across FY06–FY27.

Log in — free

Shareholding Pattern

Others3.35%Promot.65.39%FIIs4.17%Public8.56%DIIs18.52%As ofJun 2026

Documents

Frequently Asked Questions about Sheela Foam

What does Sheela Foam Ltd do?
Sheela Foam Limited is a leading player in India’s mattress and foam products industry and a leader in Polyurethane (PU) Foam. It has a nationwide presence in manufacturing PU Foam with a track record, since 1971. [1]
Where is Sheela Foam Ltd (SFL) listed?
Sheela Foam Ltd trades as SFL on the NSE and under code 540203 on the BSE.
Which sector does Sheela Foam Ltd belong to?
Sheela Foam Ltd is classified under the Consumer Discretionary sector, in the Consumer Durables industry.
What is the market capitalisation of Sheela Foam Ltd?
Sheela Foam Ltd has a market capitalisation of ₹7,605 Cr, which places it in the Mid Cap band.
What is the PE ratio of Sheela Foam Ltd?
Sheela Foam Ltd trades at a PE ratio of 35.14, on earnings per share of ₹12.09, against a book value of ₹297.79 per share.
What is the 52-week high and low of Sheela Foam Ltd?
Over the last 52 weeks Sheela Foam Ltd has traded between ₹456.8 and ₹832.45.
Does Sheela Foam Ltd pay dividends?
Sheela Foam Ltd has a dividend yield of 0.14%.
What is the Return on Equity (ROE) of Sheela Foam Ltd?
Sheela Foam Ltd reported a return on equity of 4.28%. Its debt-to-equity ratio is 0.28.

Company Information

Sheela Foam Limited is a leading player in India’s mattress and foam products industry and a leader in Polyurethane (PU) Foam. It has a nationwide presence in manufacturing PU Foam with a track record, since 1971. [1]

Website sheelafoam.com
CEO Mr. Rahul Gautam
Employees 2,622
Listed 2016-12-09
Face Value ₹ 5
Issued Size 10,87,10,778

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SFL.md for Sheela Foam Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Consumer Discretionary → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List